CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-01 | BAILEY DON M Director | Grant or award · Stock Option (Right to Buy) | −40,000 | 40,000 | ||
| 2019-07-01 | FARRELL STEPHEN C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | KINGSLEY ALFRED D Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2019-07-01 | Mulroy Michael H. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +40,000 | 40,000 | ||
| 2019-06-30 | Roberts Brandi CFO & SVP, Finance | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-05-20 | Leavitt Chase C. General Counsel/Secretary | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-04-16 | BROADWOOD PARTNERS, L.P. Director | Other acquisition | +251,835 | $1.32 | $332K | 33,980,826 |
| 2019-04-16 | BROADWOOD PARTNERS, L.P. Director | Other acquisition | +0 | 33,980,826 | ||
| 2019-03-19 | BAILEY DON M Director | Grant or award · Stock Option (Right to Buy) | −60,000 | 60,000 | ||
| 2019-03-19 | Wirth Edward Chief Medical Officer | Grant or award · Option to Purchase Common Shares | +350,000 | 350,000 | ||
| 2019-03-08 | KINGSLEY ALFRED D Director | Grant or award | +6,390 | 5,457,945 | ||
| 2019-03-08 | Mulroy Michael H. Director | Grant or award | +194,271 | 226,821 | ||
| 2019-03-08 | BROADWOOD PARTNERS, L.P. Director | Other acquisition | +3,757,430 | 33,728,991 | ||
| 2019-03-08 | BROADWOOD PARTNERS, L.P. Director | Other acquisition | +0 | 33,728,991 | ||
| 2019-01-07 | Roberts Brandi CFO & SVP, Finance | Grant or award · Option to Purchase Common Shares | +500,000 | 500,000 | ||
| 2019-01-01 | Culley Brian M President and CEO | Option exercise | +100,000 | 100,000 | ||
| 2019-01-01 | Culley Brian M President and CEO | Shares withheld for taxes | −40,880 | $0.91 | $37K | 59,120 |
| 2019-01-01 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −100,000 | 0 |
Page 12 of 17 · 322 trades